Effect of Growth Hormone on Neuropsychological Outcomes and Quality of Life of Patients with Traumatic Brain Injury: A Systematic Review.

Brain Injuries, Traumatic / psychology Cognition Growth Hormone / therapeutic use Humans Quality of Life
cognitive impairment growth hormone traumatic brain injury

Journal

Journal of neurotrauma
ISSN: 1557-9042
Titre abrégé: J Neurotrauma
Pays: United States
ID NLM: 8811626

Informations de publication

Date de publication:
01 06 2021
Historique:
pubmed: 9 3 2021
medline: 3 2 2022
entrez: 8 3 2021
Statut: ppublish

Résumé

One of the most devastating chronic consequences of traumatic brain injury (TBI) is cognitive impairment. One of the possible underlying causes is growth hormone deficiency (GHD) caused by TBI-induced hypopituitarism. Currently, TBI patients are not routinely screened for pituitary function, and there are no standard therapies when GHD is diagnosed. Further, the possible positive effects of GH replacement on cognitive function and quality of life after TBI are not well established. We aimed to assess the current knowledge regarding the effect of GH therapy on cognitive function and quality of life after TBI. We performed a literature search in PubMed, Embase, and Central

Identifiants

DOI: 10.1089/neu.2020.7265 PMID: 33677992 PMC: PMC8672110
pubmed: 33677992
doi: 10.1089/neu.2020.7265
pmc: PMC8672110
doi:

Substances chimiques

Growth Hormone 9002-72-6

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1467-1483

Subventions

Organisme : NIA NIH HHS
ID : R01 AG068295
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL077256
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG072295
Pays : United States

Références

Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Sep 10;38(9):1285-1291
pubmed: 28910948
Exp Brain Res. 2006 Aug;173(2):267-73
pubmed: 16633806
Lancet. 2001 Jun 9;357(9271):1848
pubmed: 11410194
J Int Neuropsychol Soc. 2008 Mar;14(2):233-42
pubmed: 18282321
Eur J Endocrinol. 2008 Dec;159 Suppl 1:S53-7
pubmed: 18787050
Eur J Endocrinol. 2006 Feb;154(2):259-65
pubmed: 16452539
J Gerontol A Biol Sci Med Sci. 2018 Jun 14;73(7):853-863
pubmed: 29905772
J Clin Endocrinol Metab. 2004 Oct;89(10):4929-36
pubmed: 15472187
Arch Gen Psychiatry. 1961 Jun;4:561-71
pubmed: 13688369
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Clin Endocrinol (Oxf). 2004 May;60(5):584-91
pubmed: 15104561
Geroscience. 2019 Oct;41(5):495-509
pubmed: 31676966
Brain Inj. 2010;24(3):560-7
pubmed: 20184413
J Clin Exp Neuropsychol. 1992 Sep;14(5):822-38
pubmed: 1474148
Scand J Trauma Resusc Emerg Med. 2013 Apr 20;21:33
pubmed: 23601250
J Neurotrauma. 2010 Sep;27(9):1565-75
pubmed: 20578825
Evid Based Med. 2017 Jun;22(3):85-87
pubmed: 28320705
Neurosurgery. 2008 May;62(5):1080-93; discussion 1093-4
pubmed: 18580806
J Neurotrauma. 2014 Jul 1;31(13):1161-71
pubmed: 24552537
J Cereb Blood Flow Metab. 2014 Dec;34(12):1887-97
pubmed: 25248835
J Endocrinol Invest. 2004 Dec;27(11):1048-54
pubmed: 15754737
J Alzheimers Dis. 2016;51(1):263-75
pubmed: 26836171
Aging Cell. 2017 Jun;16(3):469-479
pubmed: 28295976
Front Aging Neurosci. 2013 Jul 02;5:27
pubmed: 23847531
Geroscience. 2020 Feb;42(1):141-158
pubmed: 31808026
Pituitary. 2010 Jun;13(2):111-4
pubmed: 19847653
Age (Dordr). 2016 Aug;38(4):273-289
pubmed: 27613724
Geroscience. 2019 Dec;41(6):711-725
pubmed: 31654270
Nature. 2010 Nov 11;468(7321):232-43
pubmed: 21068832
J Neurol Neurosurg Psychiatry. 1999 Feb;66(2):207-13
pubmed: 10071101
J Neurotrauma. 2017 Feb 15;34(4):845-852
pubmed: 27627580
J Endocrinol Invest. 2010 Dec;33(11):770-5
pubmed: 20479569
Can J Neurol Sci. 2016 Nov;43(6):774-785
pubmed: 27670907
Geroscience. 2019 Dec;41(6):759-774
pubmed: 31485887
Brain Res. 1991 Apr 19;546(2):222-6
pubmed: 2070259
Am J Physiol Heart Circ Physiol. 2017 Jun 1;312(6):H1128-H1143
pubmed: 28314762
J Neurotrauma. 2013 Jun 1;30(11):998-1006
pubmed: 23323993
Clin Endocrinol (Oxf). 1996 Mar;44(3):319-24
pubmed: 8729530
Geroscience. 2019 Jun;41(3):341-349
pubmed: 31209739
Clin Endocrinol (Oxf). 2004 Sep;61(3):320-6
pubmed: 15355447
PLoS One. 2014 Apr 11;9(4):e94845
pubmed: 24728374
Signal Transduct Target Ther. 2019 Feb 8;4:3
pubmed: 30775002
J Int Neuropsychol Soc. 2007 Sep;13(5):770-80
pubmed: 17697408
J Neurol Neurosurg Psychiatry. 1983 Apr;46(4):336-44
pubmed: 6842246
Aging Cell. 2015 Dec;14(6):1034-44
pubmed: 26172407
J Neurol Neurosurg Psychiatry. 1978 May;41(5):452-7
pubmed: 660209
Neuropsychology. 2016 Oct;30(7):811-819
pubmed: 27182710
Eur J Endocrinol. 2015 Apr;172(4):371-81
pubmed: 25583905
Brain Connect. 2015 Sep;5(7):433-41
pubmed: 25490432
Geroscience. 2017 Dec;39(5-6):601-614
pubmed: 29243191
Front Endocrinol (Lausanne). 2018 Sep 10;9:520
pubmed: 30250451
Brain Inj. 2011;25(5):503-10
pubmed: 21456999
Rev Neurol (Paris). 2017 Jul - Aug;173(7-8):461-472
pubmed: 28847474
J Mol Endocrinol. 2020 Feb;64(2):115-123
pubmed: 31855559
J Clin Endocrinol Metab. 2001 Jun;86(6):2752-6
pubmed: 11397882
Brain Inj. 2011;25(1):65-73
pubmed: 21117918
J Cereb Blood Flow Metab. 2013 Nov;33(11):1732-42
pubmed: 23942363
Arch Clin Neuropsychol. 2004 Mar;19(2):203-14
pubmed: 15010086
J Neurophysiol. 2006 May;95(5):2962-74
pubmed: 16481459
Int J Evid Based Healthc. 2015 Sep;13(3):179-87
pubmed: 26262565
Ann Phys Rehabil Med. 2016 Apr;59(2):100-6
pubmed: 26704071
Horm Behav. 2013 Feb;63(2):331-44
pubmed: 22405763
Int J Mol Sci. 2015 Dec 21;16(12):30470-82
pubmed: 26703581
J Clin Endocrinol Metab. 2006 Jun;91(6):2105-11
pubmed: 16522687
Psychoneuroendocrinology. 2004 Aug;29(7):839-50
pubmed: 15177699
Geroscience. 2019 Oct;41(5):533-542
pubmed: 31679124
Redox Biol. 2019 Jun;24:101192
pubmed: 31015147
J Neurol Neurosurg Psychiatry. 1985 Jan;48(1):21-8
pubmed: 3973618
Pituitary. 2005;8(3-4):239-43
pubmed: 16508711
Geroscience. 2019 Apr;41(2):185-208
pubmed: 31076997
Orv Hetil. 2019 Nov;160(45):1774-1783
pubmed: 31680542
Geroscience. 2019 Oct;41(5):609-617
pubmed: 31643012
Am J Med. 2005 Dec;118(12):1416
pubmed: 16378796
Aging Cell. 2018 Apr;17(2):
pubmed: 29405550
Neuroscience. 2004;129(1):119-27
pubmed: 15489035
Int J Surg. 2010;8(5):336-41
pubmed: 20171303

Auteurs

Nikolett Szarka (N)

Institute for Translational Medicine, Medical School, University of Pecs, Pecs, Hungary.

Dora Szellar (D)

Department of Pediatrics, University of Pecs Medical School, Pecs, Hungary.

Szabolcs Kiss (S)

Institute for Translational Medicine, Medical School, University of Pecs, Pecs, Hungary.
Doctoral School of Clinical Medicine, University of Szeged, Szeged, Hungary.

Nelli Farkas (N)

Institute for Translational Medicine, Medical School, University of Pecs, Pecs, Hungary.

Zsolt Szakacs (Z)

Institute for Translational Medicine, Medical School, University of Pecs, Pecs, Hungary.

Andras Czigler (A)

Department of Neurosurgery and Szentagothai Research Center, University of Pecs Medical School, Pecs, Hungary.

Zoltan Ungvari (Z)

International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary.
Vascular Cognitive Impairment and Neurodegeneration Program, Reynolds Oklahoma Center on Aging/Center for Geroscience and Healthy Brain Aging, Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Peter Hegyi (P)

Institute for Translational Medicine, Medical School, University of Pecs, Pecs, Hungary.

Andras Buki (A)

Department of Neurosurgery and Szentagothai Research Center, University of Pecs Medical School, Pecs, Hungary.

Peter Toth (P)

Institute for Translational Medicine, Medical School, University of Pecs, Pecs, Hungary.
Department of Neurosurgery and Szentagothai Research Center, University of Pecs Medical School, Pecs, Hungary.
International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary.
MTA-PTE Clinical Neuroscience MR Research Group, Pecs, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Plaies et blessures › Traumatismes du système nerveux › Traumatismes cranioencéphaliques › Lésions encéphaliques › Lésions traumatiques de l'encéphale › Effect of Growth Hormone on Neuropsychological...
questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Cognition › Effect of Growth Hormone on Neuropsychological...
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Hormones peptidiques › Hormones hypophysaires › Hormones antéhypophysaires › Hormone de croissance › Effect of Growth Hormone on Neuropsychological...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Effect of Growth Hormone on Neuropsychological...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Démographie › État de santé › Qualité de vie › Effect of Growth Hormone on Neuropsychological...